Tissue microarray assessment of selenoprotein P expression in gastric adenocarcinoma

Journal of International Medical Research

Volumn 37, Issue 1, 2009, Pages 169-174

  Wang, Q ^a   Gong, L ^a   Dong, R ^a   Qiao, Q ^a   He, X L ^a   Chu, Y K ^a   Du, X L ^a   Yang, Y ^a   Zang, L ^a   Nan, J ^a   Lin, C ^b   Lu, Jian Guo ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

Author keywords

Gastric adenocarcinoma; Immunohistochemistry; Protein; Selenium; Selenoprotein P expression; Tissue microarray

Indexed keywords

SELENOPROTEIN P;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; CASE CONTROL STUDY; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH; STOMACH TUMOR;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; SELENOPROTEIN P; STOMACH; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 64149121724     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700120     Document Type: Article

References (17)

1. Xia Y, Hill KE, Byrne DW. et al: Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 2005; 81: 829-834.
2. Clark LC, Combs GF Jr, Turnbull BW, et al: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional, Prevention of Cancer Study Group, JAMA 1996; 276: 1957-1963.
3. Abdulah R, Miyazaki K, Nakazawa M, et al: Chemical forms of selenium for cancer prevention. J Trace Elem Med Biol 2005; 19: 141-150.
4. Duntas LH: The role of selenium in thyroid autoimmiunity and cancer. Thyroid 2006; 16: 455-460.
5. Sobin LH, Wittekind CH (eds): TNM Classification of Malignant Tumors, 5th edn. New York: John Wiley, 1997; pp 59-62.
6. Fang Q, Zhang MC, Zha YY, et al: Preparation and characterization of rabbit antibody against human selenoprotein P. Chin J Cell Mol Immunol 2004; 20: 91-94.
7. Al-Taie OH, Uceyler N, Eubner U, et al: Expression profiling and genetic alterations of the selenoproteins GI2GPx arid SePP in colorectal carcinogenesis. Nutr Cancer 2004; 48: 6-14.
8. Li CL, Nan KJ, Tian T, et al: Selenoprotein P mRNA expression in human hepatic tissues. World of Gastroenterol 2007; 13: 2363-2368.
9. Hawkes WC, Kelley DS, Taylor PC: The effects of dietary selenium an the immune system in healthy men. Biol Trace Elem Res 2001; 81: 189-213.
10. Shao SH, Li F, Liu JB, et al: Expression and relationship between PCNA, p16 and selenium level in gastric mucosal lesions with Helicobacter pylori infection. Guang Dong Trace Elem Sci 2004; 11: 19-24.
11. Camargo MC, Burk RF, Bravo LE, et al. Plasma selenium measurements in subjects from areas with contrasting gastric cancer risks in Colombia. Arch Med Res 2008; 39: 443-451.
12. Murawaki Y, Tsuchiya H, Kanbe T, et al: Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett 2009; 259: 218-230.
13. Burk RF, Hill KE, Motley AK: Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J Nutr 2003; 133: S1517-S1520.
14. Mörk H, al-Taie 0H, Bähr K, et al: Inverse mRNA expression of the selenocysteine-containing proteins GI-GPx and SeP in colorectal adenomas compared with adjacent normal mucosa. Nutr Cancer 2000; 37: 108-116.
15. al-Taie OH, Uceyler N, Eubner O, et al: Expression profiling arid genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis. Nutr Cancer 2004, 48: 6-14.
16. Arteel GE, Franken S, Kappler J, et al: Binding of selenoprotein P to heparin: characterization with surface plasmon resonance. Biol Chem 2000; 381: 265-268.
17. Persson-Moschos ME, Stavenow L, Akesson B, et al: Selenoprotein P in plasma in relation to cancer morbidity in middle-aged Swedish men. Nutr Cancer 2000; 36: 19-26.